CN1111068C - 一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法 - Google Patents
一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法 Download PDFInfo
- Publication number
- CN1111068C CN1111068C CN00121388A CN00121388A CN1111068C CN 1111068 C CN1111068 C CN 1111068C CN 00121388 A CN00121388 A CN 00121388A CN 00121388 A CN00121388 A CN 00121388A CN 1111068 C CN1111068 C CN 1111068C
- Authority
- CN
- China
- Prior art keywords
- capsule
- vitis viniferae
- opc
- semen vitis
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 23
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 8
- 239000002131 composite material Substances 0.000 title claims abstract description 6
- 238000000034 method Methods 0.000 title claims abstract description 5
- 229940087603 grape seed extract Drugs 0.000 title abstract description 6
- 235000002532 grape seed extract Nutrition 0.000 title abstract description 6
- 239000001717 vitis vinifera seed extract Substances 0.000 title abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- 229930182470 glycoside Natural products 0.000 claims abstract description 11
- 150000002338 glycosides Chemical class 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000012856 packing Methods 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 238000007689 inspection Methods 0.000 claims abstract description 5
- 238000011068 loading method Methods 0.000 claims abstract description 5
- 238000011049 filling Methods 0.000 claims abstract description 3
- 241000222336 Ganoderma Species 0.000 claims description 13
- 235000009392 Vitis Nutrition 0.000 claims description 13
- 241000219095 Vitis Species 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000005070 sampling Methods 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 5
- 230000036737 immune function Effects 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 238000005303 weighing Methods 0.000 abstract description 3
- -1 OPC polyphenols Chemical class 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract description 2
- 235000013824 polyphenols Nutrition 0.000 abstract description 2
- 229920001282 polysaccharide Polymers 0.000 abstract description 2
- 239000005017 polysaccharide Substances 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 229930182490 saponin Natural products 0.000 abstract description 2
- 150000007949 saponins Chemical class 0.000 abstract description 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 235000017709 saponins Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000008558 metabolic pathway by substance Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 108010038851 tannase Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
| 原料名称 | 种属 | 生产单位 | 标准文号 |
| 葡萄籽提取物 | 天然 | 蓬莱市海洋生物化工有限公司 | Q/PSHO11-98 |
| 绞股蓝总甙 | 天然 | 北医大安康药厂 | 卫药Z-03 |
| 灵芝孢子粉 | 培育 | 科技部中国科技交流中心海尔普生物技术开发公司 | 京卫药健(96)0082 |
| 维生素C粉 | 合成 | 河北维尔康制药有限公司 | 药典标准 |
| 胶囊 | 苏州胶囊厂 | 药典标准 |
Claims (3)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00121388A CN1111068C (zh) | 2000-07-27 | 2000-07-27 | 一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法 |
| PCT/CN2001/001203 WO2002011744A1 (en) | 2000-07-27 | 2001-07-25 | A strong antioxidant composite capsule containing grape seed extract opc and process for producing the same |
| AU2002214921A AU2002214921A1 (en) | 2000-07-27 | 2001-07-25 | A strong antioxidant composite capsule containing grape seed extract opc and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00121388A CN1111068C (zh) | 2000-07-27 | 2000-07-27 | 一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1280008A CN1280008A (zh) | 2001-01-17 |
| CN1111068C true CN1111068C (zh) | 2003-06-11 |
Family
ID=4588769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00121388A Expired - Fee Related CN1111068C (zh) | 2000-07-27 | 2000-07-27 | 一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法 |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1111068C (zh) |
| AU (1) | AU2002214921A1 (zh) |
| WO (1) | WO2002011744A1 (zh) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6893641B2 (en) | 1999-10-12 | 2005-05-17 | Chee-Keung Chung | Ganoderma lucidum spores for treatment of autoimmune diseases |
| US6908614B2 (en) | 1999-10-12 | 2005-06-21 | Chee-Keung Chung | Anti-aging/menopause symptoms relief using ganoderma lucidum spores |
| US7037535B2 (en) | 2002-11-19 | 2006-05-02 | Kimberly-Clark Worldwide, Inc. | Method and composition for neutralizing house dust mite feces |
| US7585518B2 (en) | 2002-11-19 | 2009-09-08 | Kimberly-Clark Worldwide, Inc. | Products and methods for maintaining or increasing ceramide levels in skin |
| US20050019379A1 (en) | 2003-07-22 | 2005-01-27 | Kimberly-Clark Worldwide, Inc. | Wipe and methods for improving skin health |
| CN100420391C (zh) * | 2006-12-18 | 2008-09-24 | 东北虎药业股份有限公司 | 一种具有减肥及抗氧化功能的保健食品 |
| CN102511826A (zh) * | 2011-12-29 | 2012-06-27 | 苏州爱斯欧蒂生物科技有限公司 | 降脂保健品及其制备方法 |
| CN103156878A (zh) * | 2013-04-11 | 2013-06-19 | 天津市园艺工程研究所 | 一种桑黃多糖opc缓释微囊 |
| CN105475999A (zh) * | 2015-11-27 | 2016-04-13 | 杭州海王生物工程有限公司 | 具有抗氧化、改善肝损伤和增强免疫力功效的组合物 |
| CN109007833A (zh) * | 2018-08-22 | 2018-12-18 | 广州市顺芝堂生物科技有限公司 | 一种调节人体免疫功能的组合物、胶囊及其制备方法 |
| CN115444894B (zh) * | 2022-09-24 | 2024-06-04 | 北京东方红航天生物技术股份有限公司 | 早期干预肝纤维化的组合物及其制备方法、制剂 |
| CN117618527B (zh) * | 2023-12-04 | 2024-10-25 | 山东益衡元健康科技有限公司 | 一种改善雄性激素水平和雄性性能力的组合物、制备方法及应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241623A (zh) * | 1999-08-18 | 2000-01-19 | 孙传经 | 超临界二氧化碳提取葡萄籽油和原花青素低聚物的方法 |
| CN1268891A (zh) * | 1997-08-06 | 2000-10-04 | 麦莱琉卡有限公司 | 一种含有天然成分的食品添加剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61104772A (ja) * | 1984-10-27 | 1986-05-23 | Osaka Chem Lab | アマチヤヅルサポニンを含む茶様清涼飲料水及びその製造法 |
| CN1083387A (zh) * | 1993-05-31 | 1994-03-09 | 季永高 | 灵芝绞股蓝口服液 |
| US5895652A (en) * | 1996-07-29 | 1999-04-20 | Longevity Institute International | Method of metabolic adjuvanation and cellular repair |
| AU1944599A (en) * | 1997-12-24 | 1999-07-19 | Shaklee Corporation | Composition with high efficiency skin protection from damaging effects of ultraviolet light |
| KR20000034037A (ko) * | 1998-11-27 | 2000-06-15 | 박인배 | 티로시나제 저해제로서의 포도씨 추출물 |
-
2000
- 2000-07-27 CN CN00121388A patent/CN1111068C/zh not_active Expired - Fee Related
-
2001
- 2001-07-25 WO PCT/CN2001/001203 patent/WO2002011744A1/zh not_active Ceased
- 2001-07-25 AU AU2002214921A patent/AU2002214921A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1268891A (zh) * | 1997-08-06 | 2000-10-04 | 麦莱琉卡有限公司 | 一种含有天然成分的食品添加剂 |
| CN1241623A (zh) * | 1999-08-18 | 2000-01-19 | 孙传经 | 超临界二氧化碳提取葡萄籽油和原花青素低聚物的方法 |
Non-Patent Citations (2)
| Title |
|---|
| 沙棘2000,13(1) 2000-01-31 刘朵花等沙棘和葡萄籽中原药青素的对比研究 * |
| 衡阳医学院学报1995,23(1) 1995-01-31 张秋菊等绞股蓝总皂甙和维生素E对实验性动脉粥样硬化兔的肝脏和心肌中SOD及LPO含量的影响 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1280008A (zh) | 2001-01-17 |
| WO2002011744A1 (en) | 2002-02-14 |
| AU2002214921A1 (en) | 2002-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101624570B (zh) | 中药培养养殖肉灵芝方法及养殖肉灵芝保健品的制备方法 | |
| CN103829238B (zh) | 一种降血脂的保健食品及其制备方法 | |
| CN1111068C (zh) | 一种葡萄籽提取物opc强抗氧化复合胶囊及其制造方法 | |
| CN104257887B (zh) | 一种促进排铅的组合物及其应用 | |
| CN101879182B (zh) | 一种用于抗辐射的复合多糖 | |
| CN105105116A (zh) | 具有缓解体力疲劳和增强免疫力的保健食品及其制备方法 | |
| CN109045059A (zh) | 一种抗衰老、提高男性精力的组合物、制剂及其制备方法与应用 | |
| CN101297704B (zh) | 一种保肝护肝保健食品及其制备方法 | |
| CN101129441B (zh) | 红景天胶囊及其制备方法 | |
| CN108713746A (zh) | 一种药食同源组合物及其制备方法和应用 | |
| CN103536622B (zh) | 羊栖菜硫酸多糖在制备抗衰老药品及保健品中的应用 | |
| CN101474383B (zh) | 大蒜总皂苷的制备方法及其产品和应用 | |
| KR20140086555A (ko) | 스피루리나음용수 | |
| CN106417817A (zh) | 一种袋泡助眠安神茶及其制备方法 | |
| CN106722258A (zh) | 一种虾青素阿胶糕及其制备方法 | |
| CN108066384A (zh) | 一种具有增强免疫力功能的中药制剂及其制备方法 | |
| CN101015345A (zh) | 一种用于耐缺氧、增强免疫力的保健食品及其制备方法 | |
| CN105410941A (zh) | 能增加骨密度和免疫力的祺然片保健食品及其制法 | |
| CN104666823B (zh) | 一种调节免疫力、延缓衰老的药物组合物及其制备方法 | |
| CN109010514A (zh) | 抗高原反应的组合物、保健品及制备方法 | |
| CN101380102A (zh) | 富硒松花粉健康食品及其制备方法 | |
| CN102146334A (zh) | 一种阿胶酒 | |
| CN115812959A (zh) | 一种蛋白肽益糖组合物及其制备方法 | |
| CN1160095C (zh) | 抗衰老养生膏及其制备方法 | |
| CN1062465C (zh) | 双五降糖胶囊 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| ASS | Succession or assignment of patent right |
Owner name: SHANGHAI BEIYIDA BIOLOGY SCIENCE CO., LTD. Free format text: FORMER OWNER: BEIJIDA MEDICAL SCIENCE AND TECHNOLOGY CO., LTD., BEIJING Effective date: 20020327 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20020327 Address after: 1009, room 841, No. 200040 middle Yanan Road, Shanghai Applicant after: Beiyida Medical Science and Technology Co., Ltd., Shanghai Address before: 100083 No. 38, Haidian District, Beijing, Xueyuan Road Applicant before: Beijida Medical Science and Technology Co., Ltd., Beijing |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |